SuperworthC4 Therapeutics shares outstanding CCCC
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 130.7M
- On a year earlier
- +84.1%
- more shares
C4 Therapeutics had 130.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 84.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 116.8M | +65% |
| FY2024 | 70.6M | +38% |
| FY2023 | 51.2M | +5% |
| FY2022 | 49M | +1% |
| FY2021 | 48.6M | +3319% |
| FY2019 | 1.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 130.7M | +84% | |
| Q1 FY26 | 126.1M | +78% | |
| Q4 FY25 | 116.8M | +65% | |
| Q3 FY25 | 72.6M | +4% | |
| Q2 FY25 | 71M | +3% | |
| Q1 FY25 | 70.8M | +4% | |
| Q4 FY24 | 70.6M | +38% | |
| Q3 FY24 | 69.6M | +41% | |
| Q2 FY24 | 68.8M | +40% | |
| Q1 FY24 | 68.4M | +40% | |
| Q4 FY23 | 51.2M | +5% | |
| Q3 FY23 | 49.2M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on C4 Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.